Legal Representation
Attorney
                                            Karl M. Zielaznicki, Esq.
                                        USPTO Deadlines
Application History
44 events| Date | Code | Type | Description | Documents | 
|---|---|---|---|---|
| Feb 20, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... | 
| Feb 20, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... | 
| Dec 18, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... | 
| Dec 18, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... | 
| Dec 18, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... | 
| Dec 18, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... | 
| Dec 18, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... | 
| Nov 4, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... | 
| Nov 4, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... | 
| Oct 30, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... | 
| Aug 2, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... | 
| Aug 2, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... | 
| Aug 2, 2024 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... | 
| May 16, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... | 
| May 16, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... | 
| Apr 23, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... | 
| Apr 23, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... | 
| Nov 7, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... | 
| Sep 12, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... | 
| Sep 12, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... | 
| Aug 23, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... | 
| Aug 7, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... | 
| Jul 27, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... | 
| Jul 26, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... | 
| Jul 26, 2023 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... | 
| Apr 27, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... | 
| Apr 27, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... | 
| Apr 27, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... | 
| Mar 27, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... | 
| Mar 27, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... | 
| Mar 27, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... | 
| Jan 9, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... | 
| Jul 7, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... | 
| Jul 7, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... | 
| Jul 7, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... | 
| May 6, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... | 
| May 5, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... | 
| May 5, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... | 
| Nov 5, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... | 
| Nov 5, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... | 
| Nov 5, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... | 
| Oct 29, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... | 
| Jul 5, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... | 
| Apr 1, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... | 
Detailed Classifications
                                                Class 042
                                            
                                        registry services, namely, conducting a registry study in the field of pharmaceuticals and providing educational information in the nature of study results in the field of pharmaceuticals for the purpose of educating healthcare practitioners
                                        Classification
                                            
                                            International Classes
                                        
                                        
                                                    042
                                            
                                        Disclaimers
                                    
                                    The following terms have been disclaimed and are not claimed as part of the trademark:
                                
                                    
                                                Specific Disclaimer
                                        
                                        
                                            "REGISTRY"